1. Home
  2. WEX vs TNGX Comparison

WEX vs TNGX Comparison

Compare WEX & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WEX Inc. common stock

WEX

WEX Inc. common stock

HOLD

Current Price

$165.05

Market Cap

5.5B

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$28.88

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEX
TNGX
Founded
1983
2014
Country
United States
United States
Employees
N/A
137
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.5B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
WEX
TNGX
Price
$165.05
$28.88
Analyst Decision
Buy
Strong Buy
Analyst Count
11
10
Target Price
$170.18
$21.78
AVG Volume (30 Days)
610.6K
4.5M
Earning Date
04-22-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
12.93
26.89
EPS
2.22
N/A
Revenue
$2,660,800,000.00
$62,384,000.00
Revenue This Year
$4.93
N/A
Revenue Next Year
$4.55
N/A
P/E Ratio
$73.96
N/A
Revenue Growth
1.24
48.29
52 Week Low
$125.29
$5.60
52 Week High
$186.86
$34.39

Technical Indicators

Market Signals
Indicator
WEX
TNGX
Relative Strength Index (RSI) 69.11 50.17
Support Level $145.44 $28.13
Resistance Level $165.13 $33.96
Average True Range (ATR) 5.70 2.01
MACD 2.35 -0.46
Stochastic Oscillator 95.14 27.89

Price Performance

Historical Comparison
WEX
TNGX

About WEX WEX Inc. common stock

WEX Inc is a commerce platform that provides seamlessly embedded, personalized payments solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. Its prime end market is the United States of America.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: